LY262691 is a selective CCKB antagonist, which decreases midbrain dopamine unit activity. References: Rasmussen K, Howbert JJ, Stockton ME. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY26269 mediation through feedback pathways from forebrain sites. Synapse. 1993 Oct;15(2):95-103. PubMed PMID: 8259526.

纯度：≥98%

CAS：138932-35-1